PO-0690: Answering questions for hypofractionated RT in Indian breast cancers: analysis of toxicities and outcomes  by Chatterjee, S. et al.
3rd ESTRO Forum 2015                                                                                                                                         S337 
 
 
 
was evaluated on a consecutive series of patients with left 
sided breast cancer. Breath hold training and the acquisition 
of an inspiratory (IN) and expiratory (EX) planning dataset 
were the basis for deciding which patients would be eligible 
for gated irradiation. After contouring of PTV, left lung, 
heart and LCV in the IN dataset, the structures were copied 
to the EX dataset and adapted nonrigidly. Treatment 
planning was performed in identical manner for both datasets 
(IMRT via mainly 2 tangential fields with up to 16 segments), 
allowing optimal comparison between IN- and EX plans. We 
also report the positioning deviations in the A-P direction 
derived from the weekly portal images. 
Results: Of the initial 26 consecutive patients, 25 could be 
CT-planned with the system resulting in 2 datasets each ( IN 
and EX). Of these, 14 (56%) were initially selected for 
treatment in inspiration due to a significant difference in one 
or more OAR. Lung gating had to be discontinued in two 
patients after 3 and 2 fractions respectively due to breath-
hold difficulties which had not been apparent during the 
training session. In patients initially selected for lung gating, 
the maximum (D02) and median (D50) doses to the LCV were 
9.5(range 2.5-48.4) Gy and 3.1(1.8-25.1) Gy, respectively, 
and were significantly lower than those derived from the EX 
plans (p<0.001). The corresponding doses for the patients not 
selected for lung gating were 35.5 (7.3-57.2) Gy and 7.0 (3.1-
39.7) Gy for D02 and D50, respectively, which was not 
significantly different from their IN plan values. Better LCV 
sparing in lung gated patients was not due to compromising 
PTV coverage: The volume of the PTV covered with 95% of 
prescribed dose was 90(73-97)% and 89(83-97)% for lung gated 
and non-lung gated patients, respectively (p=0.90).Median 
treatment times were 478±63s seconds for the lung-gated 
patients vs. 278±37s seconds for the patients treated 
without. The average A-P deviation (n=121) was 2.1 mm. 
Conclusions: These results represent the very first patients 
treated at our institution with this system. Lung-gating 
prolonged treatment time surprisingly little by approximately 
3 minutes per fraction and offered significant benefits on 
OAR sparing to 50 % of the patients. Thorax-excursion 
reproducibility is highly accurate with this system. As a 
limitation, it is only suitable for patients who are able to 
understand both the spoken and visual commands and are 
fully compliant. 
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Purpose/Objective: To compare two automated systems of 
cosmesis and skin evaluation, based on a computer assisted 
photographic assesment and a multiprobe skin tester in 
patients with breast cancer after conservative surgery and 
hypofractionated irradiation. 
Materials and Methods: 50 women with early stage breast 
carcinoma treated with conservative surgery and receiving 
whole breast irradiation and a boost were evaluated. 
Irradiation consisted in 15 whole breast fractions of 2.7 Gy 
followed by a boost to the tumor bed in 6 fractions. The 
minimal follow-up was 2 years. Patient cosmesis evaluation 
by means a validated scale was took as a reference for 
comparisons. Physician evaluation of cosmesis and skin 
toxicity was performed according Harvard scale an RTOG 
scoring criteria respectively. Patient and physician 
evaluations were compared with computerized photographic 
assessment employing a dedicated software (BCCT.Core 2.0) 
and also the analisys of hydration, elasticity and skin 
pigmentation performed by means a multiprobe skin tester 
(Multi Skin Test Center® MC750). 
Results: The most important correlation was obtained with 
computerized assisted photographic assessment and the self 
assessed patient cosmesis scoring. It has been detected that 
the best morphologic values for asymmetry in accordance to 
the patient perception of breast deformity were the BCE 
(Breast Compliance Evaluation) (p=0,018), pBRA (proportional 
Breast Retraction Assesment) (p=0,021) and pUNR 
(proportionalUpward Nipple Retraction) (p=0,023) obtained 
by the software analisys. Also a good association was 
demonstrated between the values of the chronic toxicity and 
the overall evaluation of cosmesis by means the photographic 
software (p=0,041). The multiprobe skin testing 
demonstrated differences both in pigmentation and elasticity 
in the boost area compared with the ipsilateral breast 
(p=0,011 and p=0,003 respectively) and of major magnitude 
when compared to the contralateral breast (p=0,001 and 
p=0,001 respectively). A correlation was found among the 
loss of elasticity of the boost with the patient cosmesis 
evaluation (p=0,055). Physician cosmesis evaluation was 
correlated with breast hydration loss measured by the skin 
tester probe (p=0,015). 
Conclusions: The overall cosmesis seems to be better 
evaluated by software compared to the subjective clinical 
physician evaluations. Nevertheless, the multi-probe skin 
tester device is capable to detect minor changes in elasticity 
and hydration that also correlate with patient and physician 
cosmesis evaluations respectively. 
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Purpose/Objective: Whilst moderate hypofractionation 
radiation therapy (HFRT) is routinely used in many European 
centres data supporting its use in Indians is unavailable. 
Indian patients were likely to present with more advanced 
disease and there are questions on biological dissimalirity 
between Caucasians and Indians. This analyses reports the 
demographic data, toxicity profile and control outcomes of 
the breast cancer patients. 
Materials and Methods: From May 2011 to January 2014, 496 
patients with breast cancer underwent HFRT with 3DCRT 
(4005cGy in 15 fractions) to whole breast or chest wall 
and/or supraclavicular fossa following curative surgery. The 
demographic data with respect to age, sex, neoadjuvant 
chemotherapy, type of surgery(modified radical mastectomy 
(MRM) vs Breast conservation surgery (BCS), histopathology 
(grade, tumour size, nodal status, ER/PR/Her2Neu status, 
margins and LVI), Nottingham Prognostic Index score (NPI) 
and Cambridge score were analyzed. Locoregional (LRR) and 
distant failures were analyzed using Kaplan Meier curves, 
univariate and multivariate analyses was done using the Cox 
regression model to identify predictors of failure.  
Results: The mean age at presentation was 52 years (23 – 88 
years) and 206 patients (41.6 % ) had breast conservation 
surgery. Patients who are younger than 40 years had higher 
rates of breast conservation surgery (p=0.01) irrespective of 
the tumour size. The histopathological variables and 
prognostic indexes were not significantly different across 
various age groups. The hypofractionated radiation therapy 
was well tolerated with 1.2 % and 7.1% having grade 3 and 2 
acute skin toxicity. At 6 months 13.5% had Gr 1 and 1.6% Gr 2 
lymphoedema, 5% reported distortion with no reported long 
term pneumonitis or cardiac complications. The median 
follow up period was 18.5 months. 90.2 % of the patients 
were on regular follow up. The crude LRR and distant failure 
rate was 3.42% (17 patients) and 7.66% (38 patients). In 
patients who failed loco-regionally had higher NPI score, 
greater than 70 % had node positive, tumour size > 2 cm, Gr 3 
tumours. In univariate Cox regression analysis, patients with 
positive nodal status (p=0.007), grade 3(p=0.003), MRM 
(p=0.034) and triple negative status (p=0.027) had significant 
higher distant failure rates while nodal status (p=0.005) alone 
stood significant risk factor for LRR. In multivariate analysis, 
node positivity was remained significant for locoregional 
recurrence but none of the factors were significant for 
distant metastases. The actuarial locoregional failure and 
distant metastases at 2 years were 3.4 % and 11.2% 
respectively 
Conclusions: HFRT was well tolerated and loco-regional and 
distant failure rates were comparable to the published data 
establishing its safety and effectiveness in Indian population. 
Node positivity, grade 3 and triple negative tumours are more 
aggressive and tend to have higher locoregional and distant 
failure.  
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Purpose/Objective: To report the distribution of 
radiotherapy dose within the heart of women irradiated for 
breast cancer in Sweden and Denmark between 1958 and 
2001, who later developed a major coronary event. In the 
future, these doses will be used to assess the association 
between the spatial distribution of radiation dose in the 
heart and the location of cardiac damage. 
Materials and Methods: 487 women irradiated for breast 
cancer between 1958 and 2001 and who subsequently 
developed a major coronary event with known location of 
cardiac damage were included in the study. Each woman's 
radiotherapy chart was reviewed, and categorised according 
to the regimen used. The four most commonly used 
treatment regimens were reconstructed on 10 randomly 
selected CT planning scans of women irradiated for breast 
cancer at Odense University Hospital in the year 2010. One 
representative patient was selected who was typical for 
mean cardiac doses. All regimens identified were then 
reconstructed on the representative patient. Doses were 
extracted from dose volume histograms for five left 
ventricular and ten coronary arterial segments, which 
matched the different sites of cardiac damage for the women 
studied. Several sources of dosimetric uncertainty were 
considered. 
Results: 31 regimens were identified and these were further 
categorised into six: left and right tangential irradiation, left 
and right direct electron or orthovoltage irradiation and left 
and right direct megavoltage regimens. The estimated mean 
heart dose ranged from 3-27Gy for left-sided treatment and 
0.6-27Gy for right-sided treatment. Doses to different 
segments of the left ventricle varied substantially e.g. left 
tangential irradiation delivered 10-48Gy to the apex but only 
0.3-5Gy to the inferior segment. Coronary artery doses also 
varied between regimens. Left-sided regimens resulted in 
highest doses (3-46Gy) to the left anterior descending 
coronary artery whereas right-sided regimens gave highest 
